Rebekah Robinson
- Ophthalmology top 5%
- Retinal Diseases and Treatments 8
- Glaucoma and retinal disorders 2
-
- Neuroinflammation and Neurodegeneration Mechanisms 2
-
- Advanced Glycation End Products research 2
-
- interferon and immune responses 2
- Atherosclerosis and Cardiovascular Diseases 2
-
- Retinoids in leukemia and cellular processes 2
-
- Systemic Lupus Erythematosus Research 2
Rebekah Robinson
15 papers receiving 315 citations
Peers
Comparison fields: 5 of 80
- Ophthalmology 141
- Neurology 45
- Clinical Biochemistry 21
- Immunology 55
- Radiology, Nuclear Medicine and Imaging 57
Countries citing papers authored by Rebekah Robinson
This map shows the geographic impact of Rebekah Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebekah Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebekah Robinson more than expected).
Fields of papers citing papers by Rebekah Robinson
This network shows the impact of papers produced by Rebekah Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebekah Robinson. The network helps show where Rebekah Robinson may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Rebekah Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 16 | |
| 4 | 2022 | 3 | |
| 5 | RNA-Seq reveals IL-6 trans-signaling mediated regulation of paracellular permeability in human retinal endothelial cells | 2021 | 0 |
| 6 | 2021 | 4 | |
| 7 | 2020 | 14 | |
| 8 | 2020 | 60 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 29 | |
| 11 | Inhibition of IL-6 trans-signaling prevents oxidative stress and lipid peroxidation in early diabetic retinopathy. | 2019 | 1 |
| 12 | 2019 | 124 | |
| 13 | 2017 | 12 | |
| 14 | 2016 | 1 | |
| 15 | 2016 | 3 | |
| 16 | 2015 | 10 | |
| 17 | 1981 | 28 |
About Rebekah Robinson
Rebekah Robinson is a scholar working on Ophthalmology, Neurology and Clinical Biochemistry, having authored 17 papers that have together received 321 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (8 papers), interferon and immune responses (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Glaucoma and retinal disorders (2 papers), Retinoids in leukemia and cellular processes (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Advanced Glycation End Products research (2 papers). The work is most often cited by research in Ophthalmology (141 citations), Neurology (45 citations) and Clinical Biochemistry (21 citations). Rebekah Robinson has collaborated with scholars based in United States. Frequent co-authors include Shruti Sharma, Ashok Sharma, Hannah Youngblood, Alexander H. Ward, Tae Jin Lee, Katsutoshi Goto, Peter W. Abel, P. R. Urquilla, William W. Fleming and D P Westfall. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.